Everything tagged "financial services" across the TickerSpark archives.
Piraeus Bank is delivering stronger earnings, faster fee growth, and solid loan expansion, but the stock already reflects much of the improvement. The report rates it Hold with a fair value of $10.25.
TransUnion delivered 15% Q2 revenue growth, beat adjusted EPS expectations, and raised its 2026 outlook, yet shares plunged 15.4% after hours. That disconnect makes TRU a contrarian buy setup, with execution and guidance—not the selloff itself—as the key test.
TransUnion is delivering strong organic growth as analytics, fraud, identity, and international expansion reduce reliance on traditional credit reporting. The stock earns a Buy on solid execution, though valuation and leverage keep the upside tied to continued product momentum.
Nu Holdings is delivering rapid revenue and earnings growth, but rising delinquencies and a still-developing credit book keep the risk profile elevated. The report supports a Buy case on scale, profitability, and balance sheet strength.
Manulife combines strong Asia growth, improving wealth-management earnings, and solid capital with a valuation that still looks reasonable. The report supports a Buy view as execution improves across its highest-growth businesses.
Carlyle posted record second-quarter results, including $358M of Fee Related Earnings and $485B of AUM, but the stock already prices in much of the recovery. The report keeps CG at Hold with a fair value estimate of $58.06.
Pershing Square Inc. (PS) rises after an EPS beat, but the deeper read is mixed: revenue missed estimates and the quarterly trend remains uneven. This analysis goes beyond the headline to examine prior results, revenue softness, and why the stock’s 7.68% move may reflect cautious optimism.
Pershing Square is scaling fee-paying AUM fast, but rich valuation and negative cash flow keep the stock at Hold. The new PSUS vehicle expands distribution, yet execution risk remains high.
Pershing Square Inc. (PS) gains 2.8% after reporting earnings beats, lifting investor sentiment as the stock reacts positively to stronger-than-expected results.
Brookfield is a Buy as fee-bearing capital, insurance assets, and fundraising momentum continue to scale. Leverage and uneven earnings quality temper the case, but the long-term asset-management and Wealth Solutions engines support upside.
Pelagos Insurance Capital Limit (PLGO) slips after a sharp EPS miss, with results that fall well below consensus and break from recent profit strength. This deep-dive earnings analysis goes beyond the headline to examine underwriting margins, premium growth, capital returns, and what the latest quarter may mean for the stock.
Pelagos Insurance Capital earns a Buy on improving underwriting, a 86.6% combined ratio, and a low earnings multiple. The main debate is whether specialty growth and disciplined capital allocation can outweigh volatile insurance earnings and negative operating cash flow.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the GeneratorCancel anytime